Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29664W105

Event date: 2015-06-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,335,101
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-15-000039
Form type
SC 13G
Filer
Esperion Therapeutics, Inc.
CIK
CIK 1434868
Filed
Jun 29, 2015
Reporting period
Jun 18, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub